Orgenesis (ORGS) Insider Trading & Ownership $2.01 0.00 (0.00%) As of 05/21/2025 Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock Orgenesis (NASDAQ:ORGS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.66%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$29,483.00Number OfInsiders Selling(Last 3 Years)0 Get ORGS Insider Trade Alerts Want to know when executives and insiders are buying or selling Orgenesis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ORGS Insider Buying and Selling by Quarter Orgenesis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/1/2024Jacob SafierMajor ShareholderBuy1,010$3.30$3,333.00 1/30/2024Jacob SafierMajor ShareholderBuy2,500$3.30$8,250.00 1/25/2024Jacob SafierMajor ShareholderBuy2,500$3.20$8,000.00 1/22/2024Jacob SafierMajor ShareholderBuy1,000$2.90$2,900.00 1/18/2024Jacob SafierMajor ShareholderBuy1,000$3.30$3,300.00 1/10/2024Jacob SafierMajor ShareholderBuy1,000$3.70$3,700.00 (Data available from 1/1/2013 forward) ORGS Insider Trading Activity - Frequently Asked Questions Who is on Orgenesis's Insider Roster? The list of insiders at Orgenesis includes Jacob Safier. Learn more on insiders at ORGS. What percentage of Orgenesis stock is owned by insiders? 5.66% of Orgenesis stock is owned by insiders. Learn more on ORGS's insider holdings. Which Orgenesis insiders have been buying company stock? The following insider purchased ORGS shares in the last 24 months: Jacob Safier ($29,483.00). How much insider buying is happening at Orgenesis? Insiders have purchased a total of 9,010 ORGS shares in the last 24 months for a total of $29,483.00 bought. Orgenesis Key ExecutivesMs. Vered Caplan M.Sc. (Age 55)Chairperson of the Board, CEO & President Compensation: $341.38kProf. Sarah Ferber Ph.D. (Age 70)Founder & Chief Scientific Officer Compensation: $268.32kMr. Victor Miller (Age 54)CFO, Secretary & Treasurer Pierre LammeretzInterim Chief Operating OfficerDr. Shimon Hassin Ph.D.Chief Technology OfficerMr. Evan FishmanChief Financial Officer of Orgenesis BiotechMr. Joseph CarpinelliChief Financial Officer of Octomera More Insider Trading Tools from MarketBeat Related Companies Alzamend Neuro Insider Trades OS Therapies Insider Trades Reviva Pharmaceuticals Insider Trades Celularity Insider Trades Iterum Therapeutics Insider Trades Tenaya Therapeutics Insider Trades NRx Pharmaceuticals Insider Trades Eliem Therapeutics Insider Trades Rani Therapeutics Insider Trades Aligos Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Turbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market Cap This page (NASDAQ:ORGS) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orgenesis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orgenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ORGS Stock Free ORGS Stock Alerts